NCT04884321

Brief Summary

Complementary and alternative medicine is frequently used in the treatment of several groups of diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,242

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 27, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 7, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 12, 2021

Completed
Last Updated

May 12, 2021

Status Verified

May 1, 2021

Enrollment Period

1 month

First QC Date

May 7, 2021

Last Update Submit

May 7, 2021

Conditions

Complementary Therapies

Keywords

Complementary TherapiesCOVID-19Complementary and Alternative MedicineAttitude

Outcome Measures

Primary Outcomes (5)

  • Participant adults' responses to the questions raised about the use of complementary and alternative methods during the COVID-19 pandemic

    2021

  • Means of scores obtained by participant adults from the holistic complementary and alternative medicine questionnaire (HCAMQ) and its sub-scales

    Holistic Complementary and Alternative Medicine Questionnaire

    2021

  • Complementary and alternative treatment methods used during the COVID-19 pandemic

    2021

  • Plants consumed during the COVID-19 pandemic

    2021

  • Symptoms against which complementary and alternative methods are used during the COVID-19 pandemic

    2021

Interventions

Complementary And Alternative MedicineOTHER

No intervention was done in the cross-sectional study

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The research population was comprised of Turkish citizens who resided in Turkey and were aged 18-65 years.

You may qualify if:

  • agree to participate in the study
  • not to be a communication problem

You may not qualify if:

  • be a communication problem

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasan Kalyoncu Ünivrsitesi

Gaziantep, Lütfen Seç, 27000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19Behavior

Interventions

Complementary Therapies

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 7, 2021

First Posted

May 12, 2021

Study Start

February 27, 2021

Primary Completion

March 30, 2021

Study Completion

March 30, 2021

Last Updated

May 12, 2021

Record last verified: 2021-05

Locations

TU(1)